Sonoma Pharmaceuticals shares rise 9.73% after Q1 revenue jumps to $6.4 million

The company narrowed its quarterly loss to 9 cents per share, posted positive EBITDA for the first time in its history, and said U.S. sales surged 141%.

19d ago